Fractyl Health, Inc. (GUTS)
0.7318
+0.07
(+10.19%)
USD |
NASDAQ |
Jun 10, 16:00
0.7391
+0.01
(+1.00%)
After-Hours: 07:26
Fractyl Health Enterprise Value : 113.75M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 113.75M |
| June 09, 2026 | 103.01M |
| June 08, 2026 | 103.94M |
| June 05, 2026 | 105.31M |
| June 04, 2026 | 114.03M |
| June 03, 2026 | 118.22M |
| June 02, 2026 | 122.93M |
| June 01, 2026 | 135.23M |
| May 29, 2026 | 125.55M |
| May 28, 2026 | 131.07M |
| May 27, 2026 | 133.96M |
| May 26, 2026 | 143.26M |
| May 22, 2026 | 141.96M |
| May 21, 2026 | 143.61M |
| May 20, 2026 | 143.81M |
| May 19, 2026 | 127.28M |
| May 18, 2026 | 125.58M |
| May 15, 2026 | 134.18M |
| May 14, 2026 | 149.00M |
| May 13, 2026 | 148.10M |
| May 12, 2026 | 114.10M |
| May 11, 2026 | 119.65M |
| May 08, 2026 | 117.38M |
| May 07, 2026 | 116.33M |
| May 06, 2026 | 114.29M |
| Date | Value |
|---|---|
| May 05, 2026 | 107.74M |
| May 04, 2026 | 113.00M |
| May 01, 2026 | 108.59M |
| April 30, 2026 | 98.79M |
| April 29, 2026 | 93.16M |
| April 28, 2026 | 101.77M |
| April 27, 2026 | 101.26M |
| April 24, 2026 | 96.01M |
| April 23, 2026 | 89.82M |
| April 22, 2026 | 91.33M |
| April 21, 2026 | 88.87M |
| April 20, 2026 | 88.95M |
| April 17, 2026 | 87.98M |
| April 16, 2026 | 79.26M |
| April 15, 2026 | 83.32M |
| April 14, 2026 | 78.35M |
| April 13, 2026 | 75.39M |
| April 10, 2026 | 70.63M |
| April 09, 2026 | 72.18M |
| April 08, 2026 | 71.44M |
| April 07, 2026 | 69.10M |
| April 06, 2026 | 70.15M |
| April 02, 2026 | 69.98M |
| April 01, 2026 | 71.37M |
| March 31, 2026 | 70.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 11.38M |
| Spectral AI, Inc. | 56.52M |
| Replimune Group, Inc. | 481.69M |
| Lantern Pharma, Inc. | 37.40M |
| Arrowhead Pharmaceuticals, Inc. | 9.517B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.218M |
| Total Expenses (Quarterly) | -9.218M |
| EPS Diluted (Quarterly) | 0.0582 |
| Earnings Yield | -205.1% |
| Normalized Earnings Yield | -171.66 |